| Product Information |
|
| Registration Number |
BR-1337
|
| Generic Name |
Bevacizumab
|
| Brand Name |
Mvasi
|
| Dosage Strength |
400 mg/16 mL (25 mg/mL)
|
| Dosage Form |
Concentrate For Solution For Infusion (IV)
|
| Classification |
Prescription Drug (Rx)
|
| Packaging |
20 mL USP/EP Type I clear, colorless glass vial with light gray elastomeric stopper and blue aluminum seal with green polypropylene flip-off cap (Box of l's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Amgen Manufacturing Limited
|
| Country of Origin |
USA
|
| Trader |
|
| Importer |
Zuellig Pharma Corporation
|
| Distributor |
Zuellig Pharma Corporation
|
| Application Type |
Initial
|
| Issuance Date |
28 January 2021
|
| Expiry Date |
28 January 2026
|